The rising prevalence in GLP-1 agonists for diabetes has generated a question about application forms : transdermal systems versus tablets . Traditionally , GLP-1 drugs were only available in oral form, https://keithdnho004553.pages10.com/glp-1-skin-applications-vs-pills-is-suitable-for-the-patient-76367139